In the fireside chat at Techonomy 24, Aloe Blacc, a Grammy-nominated singer and songwriter, shared his journey from being a Management Consultant in the health sector to venturing into the biotech industry as the CEO of Major Inc. Blacc discussed how his initial work at hospitals and his personal battles during the pandemic motivated him to contribute to healthcare innovation. Experiencing COVID-19 despite being vaccinated and boosted, he became acutely aware of the necessity for prophylactics and began to explore scientific research on SARS-CoV-2. With his background in neuroscience, he educated himself about the virus’s mechanisms and connected with Dr. Gomika Udugamasooriya of the University of Houston to explore innovative solutions. Together, they initiated a project to block the interaction between the spike protein and the ACE-2 protein, and Blacc sponsored the research that yielded successful results in animal models. This catalyzed the formation of Major Inc., where he discusses the challenges of financing biotech endeavors, emphasizing the “valley of death” predicament due to insufficient funding during pre-clinical stages. Blacc also explored the role of artificial intelligence in transforming drug discovery and development. He sees AI as a vital component in enhancing collaboration among scientists, improving predictive modeling, and refining drug discovery through historical data analysis. Although Blacc expressed optimism about AI’s potential in healthcare, he acknowledged the current barriers posed by regulatory bodies like the FDA, expressing the hope for a future where technology could aid in making healthcare more efficient and effective. The chat concluded with his optimistic view that AI technology might allow people to work less and spend more time experiencing life with loved ones.

Watch the Session